Oxnard: Used PI AURA trial, sent to BEAMing (Sysmex-Inostics) w/AstraZeneca. '16 JCO https://t.co/D6g3B6jZBQ T790M neg do better #FDA-AACR

10:24am July 19th 2016 via Hootsuite